Ex Parte Petersen et al - Page 23


             Appeal No. 2006-2627                                                            Page 23                
             Application No. 09/947,833                                                                             

             art.  For clarity, I direct attention to the following documents: Sottosanti18, Hanker19 and           
             Snyders20.  Each of these patents issued prior to the filing date of appellants’                       
             application, each teach bone repair compositions21, each is discussed in appellants’                   
             specification and each is of record in the instant application22.  Therefore, each                     
             document informs this record as to what a person of ordinary skill in this art, specifically           
             a person with experience in the formulation of bone repair compositions23, knew and                    
             understood at the time of appellants’ claimed invention.                                               
                    Each patent teaches a composition that comprises demineralized bone and                         
             calcium sulfate.  See Sottosanti, column 2, lines 24-26 (“[t]he present invention also                 
             provides a novel composite graft material containing DFDBA24 and calcium sulfate.”);                   
             Hanker, column 2, lines 24-25 (“demineralized freeze-dried bone can be mixed with the                  
             plaster25 and calcium phosphate ceramic.”); and Snyders, column 3, lines 51-54 (“[y]et                 



                                                                                                                    
             18 Sottosanti, U.S. Patent No. 5,366,507, issued November 22, 1994                                     
             19 Hanker et al. (Hanker), U.S. Patent No. 4,619,655, issued October 28, 1986                          
             20 Snyders, U.S. Patent No. 5,425,769, issued June 20, 1995                                            
             21 See Sottosanti, column 1, lines 6-13; Hanker, column 1, lines 12-13; and Snyders, column 1,         
             lines 10-12.                                                                                           
             22 See Form PTO-1449, received April 3, 2002 and included, as considered by the examiner, in the Office
             Action mailed July 2, 2002.                                                                            
             23 There is no dispute on this record that a person of ordinary skill in this art is a person with experience in
             the formulation of bone graft compositions.                                                            
             24 Sottosanti defines DFDBA as “[d]emineralized, freeze-dried, allogenic bone. . . .”  Sottosanti, column 1,
             lines 28-29.                                                                                           
             25 According to Hanker (column 1, lines 15-17), “Plaster of Paris (PP) or equivalent forms of calcium  
             sulfate hemihydrate, [are] hereinafter referred to for convenience as ‘plaster’. . . .”                






Page:  Previous  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  Next 

Last modified: November 3, 2007